{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:14:16Z","timestamp":1788840856118,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO.82271960 and NO.22327901"],"award-info":[{"award-number":["NO.82271960 and NO.22327901"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2024AFB179"],"award-info":[{"award-number":["2024AFB179"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07464-5","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:07:04Z","timestamp":1764317224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["5T chemical exchange saturation transfer imaging improves glioma grading and genotyping prediction: a supplement to 3T diffusion and perfusion MRI"],"prefix":"10.1186","volume":"24","author":[{"given":"Jie","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Topgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8451-8979","authenticated-orcid":false,"given":"Haibo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"7464_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","volume":"21","author":"K Yang","year":"2022","unstructured":"Yang K, Wu Z, Zhang H, Zhang N, Wu W, Wang Z, et al. Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer. 2022;21:39. https:\/\/doi.org\/10.1186\/s12943-022-01513-z.","journal-title":"Mol Cancer"},{"key":"7464_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","volume":"41","author":"L Rong","year":"2022","unstructured":"Rong L, Li N, Zhang Z. Emerging therapies for glioblastoma: current state and future directions. J Exp Clin Cancer Res. 2022;41:142. https:\/\/doi.org\/10.1186\/s13046-022-02349-7.","journal-title":"J Exp Clin Cancer Res"},{"key":"7464_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23:1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106.","journal-title":"Neuro Oncol"},{"key":"7464_CR4","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, et al. Comprehensive, integrative genomic analysis of diffuse Lower-Grade gliomas. N Engl J Med. 2015;372:2481\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1402121.","journal-title":"N Engl J Med"},{"key":"7464_CR5","doi-asserted-by":"publisher","first-page":"CD8218","DOI":"10.1002\/14651858.CD008218.pub4","volume":"11","author":"M Ameratunga","year":"2018","unstructured":"Ameratunga M, Pavlakis N, Wheeler H, Grant R, Simes J, Khasraw M. Anti-angiogenic therapy for high-grade glioma. Cochrane Database Syst Rev. 2018;11:CD8218. https:\/\/doi.org\/10.1002\/14651858.CD008218.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"7464_CR6","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1158\/1078-0432.CCR-06-0596","volume":"12","author":"A Chakravarti","year":"2006","unstructured":"Chakravarti A, Erkkinen MG, Nestler U, Stupp R, Mehta M, Aldape K, et al. Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms. Clin Cancer Res. 2006;12:4738\u201346. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0596.","journal-title":"Clin Cancer Res"},{"key":"7464_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1148\/radiol.2020191832","volume":"296","author":"J Maynard","year":"2020","unstructured":"Maynard J, Okuchi S, Wastling S, Busaidi AA, Almossawi O, Mbatha W, et al. World health organization grade II\/III glioma molecular status: prediction by MRI morphologic features and apparent diffusion coefficient. Radiology. 2020;296:111\u201321. https:\/\/doi.org\/10.1148\/radiol.2020191832.","journal-title":"Radiology"},{"key":"7464_CR8","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.acra.2019.12.010","volume":"27","author":"HW Zhang","year":"2020","unstructured":"Zhang HW, Lyu GW, He WJ, Lei Y, Lin F, Wang MZ, et al. DSC and DCE histogram analyses of glioma Biomarkers, including IDH, MGMT, and TERT, on differentiation and survival. Acad Radiol. 2020;27:e263\u201371. https:\/\/doi.org\/10.1016\/j.acra.2019.12.010.","journal-title":"Acad Radiol"},{"key":"7464_CR9","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3174\/ajnr.A5171","volume":"38","author":"Z Xing","year":"2017","unstructured":"Xing Z, Yang X, She D, Lin Y, Zhang Y, Cao D. Noninvasive assessment of IDH mutational status in world health organization grade II and III Astrocytomas using DWI and DSC-PWI combined with conventional MR imaging. AJNR Am J Neuroradiol. 2017;38:1138\u201344. https:\/\/doi.org\/10.3174\/ajnr.A5171.","journal-title":"AJNR Am J Neuroradiol"},{"key":"7464_CR10","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1007\/s00330-021-08522-4","volume":"32","author":"Y Sun","year":"2022","unstructured":"Sun Y, Su C, Deng K, Hu X, Xue Y, Jiang R. Mean apparent propagator-MRI in evaluation of glioma grade, cellular proliferation, and IDH-1 gene mutation status. Eur Radiol. 2022;32:3744\u201354. https:\/\/doi.org\/10.1007\/s00330-021-08522-4.","journal-title":"Eur Radiol"},{"key":"7464_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nm.2615","volume":"18","author":"K Cai","year":"2012","unstructured":"Cai K, Haris M, Singh A, Kogan F, Greenberg JH, Hariharan H, et al. Magnetic resonance imaging of glutamate. Nat Med. 2012;18:302\u20136. https:\/\/doi.org\/10.1038\/nm.2615.","journal-title":"Nat Med"},{"key":"7464_CR12","doi-asserted-by":"publisher","first-page":"119191","DOI":"10.1016\/j.neuroimage.2022.119191","volume":"256","author":"A Cember","year":"2022","unstructured":"Cember A, Deck BL, Kelkar A, Faseyitan O, Zimmerman JP, Erickson B, et al. Glutamate-Weighted magnetic resonance imaging (GluCEST) detects effects of transcranial magnetic stimulation to the motor cortex. NeuroImage. 2022;256:119191. https:\/\/doi.org\/10.1016\/j.neuroimage.2022.119191.","journal-title":"NeuroImage"},{"key":"7464_CR13","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/nbm.2949","volume":"26","author":"K Cai","year":"2013","unstructured":"Cai K, Singh A, Roalf DR, Nanga RP, Haris M, Hariharan H, et al. Mapping glutamate in subcortical brain structures using high-resolution glucest MRI. NMR Biomed. 2013;26:1278\u201384. https:\/\/doi.org\/10.1002\/nbm.2949.","journal-title":"NMR Biomed"},{"key":"7464_CR14","doi-asserted-by":"publisher","first-page":"e4780","DOI":"10.1002\/nbm.4780","volume":"36","author":"A Cember","year":"2023","unstructured":"Cember A, Nanga R, Reddy R. Glutamate-weighted CEST (gluCEST) imaging for mapping neurometabolism: an update on the state of the Art and emerging findings from in vivo applications. NMR Biomed. 2023;36:e4780. https:\/\/doi.org\/10.1002\/nbm.4780.","journal-title":"NMR Biomed"},{"key":"7464_CR15","doi-asserted-by":"publisher","first-page":"309ra161","DOI":"10.1126\/scitranslmed.aaa7095","volume":"7","author":"KA Davis","year":"2015","unstructured":"Davis KA, Nanga RP, Das S, Chen SH, Hadar PN, Pollard JR, et al. Glutamate imaging (GluCEST) lateralizes epileptic foci in nonlesional Temporal lobe epilepsy. Sci Transl Med. 2015;7:309ra161. https:\/\/doi.org\/10.1126\/scitranslmed.aaa7095.","journal-title":"Sci Transl Med"},{"key":"7464_CR16","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/mp.2016.258","volume":"22","author":"DR Roalf","year":"2017","unstructured":"Roalf DR, Nanga R, Rupert PE, Hariharan H, Quarmley M, Calkins ME, et al. Glutamate imaging (GluCEST) reveals lower brain glucest contrast in patients on the psychosis spectrum. Mol Psychiatry. 2017;22:1298\u2013305. https:\/\/doi.org\/10.1038\/mp.2016.258.","journal-title":"Mol Psychiatry"},{"key":"7464_CR17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/nbm.2875","volume":"26","author":"M Haris","year":"2013","unstructured":"Haris M, Nath K, Cai K, Singh A, Crescenzi R, Kogan F, et al. Imaging of glutamate neurotransmitter alterations in alzheimer\u2019s disease. NMR Biomed. 2013;26:386\u201391. https:\/\/doi.org\/10.1002\/nbm.2875.","journal-title":"NMR Biomed"},{"key":"7464_CR18","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1038\/s41598-018-21035-3","volume":"8","author":"P Bagga","year":"2018","unstructured":"Bagga P, Pickup S, Crescenzi R, Martinez D, Borthakur A, D\u2019Aquilla K, et al. In vivo glucest MRI: Reproducibility, background contribution and source of glutamate changes in the MPTP model of parkinson\u2019s disease. Sci Rep. 2018;8:2883. https:\/\/doi.org\/10.1038\/s41598-018-21035-3.","journal-title":"Sci Rep"},{"key":"7464_CR19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/mrm.22423","volume":"64","author":"S Chung","year":"2010","unstructured":"Chung S, Kim D, Breton E, Axel L. Rapid B1 + mapping using a preconditioning RF pulse with turboflash readout. Magn Reson Med. 2010;64:439\u201346. https:\/\/doi.org\/10.1002\/mrm.22423.","journal-title":"Magn Reson Med"},{"key":"7464_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11060-024-04759-3","volume":"169","author":"J Zhou","year":"2024","unstructured":"Zhou J, Sun W, Li H, Song X, Xu D, Xu H. Application of 5T glutamate chemical exchange saturation transfer imaging in brain tumors: preliminary results. J Neurooncol. 2024;169:581\u20139. https:\/\/doi.org\/10.1007\/s11060-024-04759-3.","journal-title":"J Neurooncol"},{"key":"7464_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/bpa.12367","volume":"27","author":"A Zacher","year":"2017","unstructured":"Zacher A, Kaulich K, Stepanow S, Wolter M, Kohrer K, Felsberg J, et al. Molecular diagnostics of gliomas using next generation sequencing of a Glioma-Tailored gene panel. Brain Pathol. 2017;27:146\u201359. https:\/\/doi.org\/10.1111\/bpa.12367.","journal-title":"Brain Pathol"},{"key":"7464_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00234-022-03072-y","volume":"65","author":"NS Cho","year":"2023","unstructured":"Cho NS, Hagiwara A, Sanvito F, Ellingson BM. A multi-reader comparison of normal-appearing white matter normalization techniques for perfusion and diffusion MRI in brain tumors. Neuroradiology. 2023;65:559\u201368. https:\/\/doi.org\/10.1007\/s00234-022-03072-y.","journal-title":"Neuroradiology"},{"key":"7464_CR23","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/neuonc\/noab276","volume":"24","author":"A Hagiwara","year":"2022","unstructured":"Hagiwara A, Oughourlian TC, Cho NS, Schlossman J, Wang C, Yao J, et al. Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors. Neuro Oncol. 2022;24:1020\u20138. https:\/\/doi.org\/10.1093\/neuonc\/noab276.","journal-title":"Neuro Oncol"},{"key":"7464_CR24","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s00330-017-5182-4","volume":"28","author":"S Jiang","year":"2018","unstructured":"Jiang S, Rui Q, Wang Y, Heo HY, Zou T, Yu H, et al. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics. Eur Radiol. 2018;28:2115\u201323. https:\/\/doi.org\/10.1007\/s00330-017-5182-4.","journal-title":"Eur Radiol"},{"key":"7464_CR25","doi-asserted-by":"publisher","first-page":"101694","DOI":"10.1016\/j.nicl.2019.101694","volume":"22","author":"A Neal","year":"2019","unstructured":"Neal A, Moffat BA, Stein JM, Nanga R, Desmond P, Shinohara RT, et al. Glutamate weighted imaging contrast in gliomas with 7 Tesla magnetic resonance imaging. Neuroimage Clin. 2019;22:101694. https:\/\/doi.org\/10.1016\/j.nicl.2019.101694.","journal-title":"Neuroimage Clin"},{"key":"7464_CR26","doi-asserted-by":"publisher","first-page":"e163765","DOI":"10.1371\/journal.pone.0163765","volume":"11","author":"G Yan","year":"2016","unstructured":"Yan G, Zhang T, Dai Z, Yi M, Jia Y, Nie T, et al. A potential magnetic resonance imaging technique based on chemical exchange saturation transfer for in vivo gamma-Aminobutyric acid imaging. PLoS ONE. 2016;11:e163765. https:\/\/doi.org\/10.1371\/journal.pone.0163765.","journal-title":"PLoS ONE"},{"key":"7464_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainres.2019.04.010","volume":"1717","author":"DH Lee","year":"2019","unstructured":"Lee DH, Lee DW, Kwon JI, Kim ST, Woo CW, Kon KJ, et al. Changes to gamma-aminobutyric acid levels during short-term epileptiform activity in a Kainic acid-induced rat model of status epilepticus: A chemical exchange saturation transfer imaging study. Brain Res. 2019;1717:176\u201381. https:\/\/doi.org\/10.1016\/j.brainres.2019.04.010.","journal-title":"Brain Res"},{"key":"7464_CR28","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/s42255-024-01082-z","volume":"6","author":"Z Cai","year":"2024","unstructured":"Cai Z, Zhong Q, Feng Y, Wang Q, Zhang Z, Wei C, et al. Non-invasive mapping of brown adipose tissue activity with magnetic resonance imaging. Nat Metab. 2024;6:1367\u201379. https:\/\/doi.org\/10.1038\/s42255-024-01082-z.","journal-title":"Nat Metab"},{"key":"7464_CR29","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/nm0901-1010","volume":"7","author":"T Takano","year":"2001","unstructured":"Takano T, Lin JH, Arcuino G, Gao Q, Yang J, Nedergaard M. Glutamate release promotes growth of malignant gliomas. Nat Med. 2001;7:1010\u20135. https:\/\/doi.org\/10.1038\/nm0901-1010.","journal-title":"Nat Med"},{"key":"7464_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65:1\u2013105. https:\/\/doi.org\/10.1016\/s0301-0082(00)00067-8.","journal-title":"Prog Neurobiol"},{"key":"7464_CR31","first-page":"4383","volume":"59","author":"ZC Ye","year":"1999","unstructured":"Ye ZC, Sontheimer H. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res. 1999;59:4383\u201391.","journal-title":"Cancer Res"},{"key":"7464_CR32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11060-017-2613-7","volume":"135","author":"RL Delfanti","year":"2017","unstructured":"Delfanti RL, Piccioni DE, Handwerker J, Bahrami N, Krishnan A, Karunamuni R, et al. Imaging correlates for the 2016 update on WHO classification of grade II\/III gliomas: implications for IDH, 1p\/19q and ATRX status. J Neurooncol. 2017;135:601\u20139. https:\/\/doi.org\/10.1007\/s11060-017-2613-7.","journal-title":"J Neurooncol"},{"key":"7464_CR33","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, et al. The epidemiology of glioma in adults: a state of the science review. Neuro Oncol. 2014;16:896\u2013913. https:\/\/doi.org\/10.1093\/neuonc\/nou087.","journal-title":"Neuro Oncol"},{"key":"7464_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/gcc.22323","volume":"55","author":"Y Liu","year":"2016","unstructured":"Liu Y, Hu H, Zhang C, Wang Z, Li M, Jiang T. Integrated analysis identified genes associated with a favorable prognosis in oligodendrogliomas. Genes Chromosomes Cancer. 2016;55:169\u201376. https:\/\/doi.org\/10.1002\/gcc.22323.","journal-title":"Genes Chromosomes Cancer"},{"key":"7464_CR35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/sj.bjc.6602048","volume":"91","author":"S Palfi","year":"2004","unstructured":"Palfi S, Swanson KR, De Bouard S, Chretien F, Oliveira R, Gherardi RK, et al. Correlation of in vitro infiltration with glioma histological type in organotypic brain slices. Br J Cancer. 2004;91:745\u201352. https:\/\/doi.org\/10.1038\/sj.bjc.6602048.","journal-title":"Br J Cancer"},{"key":"7464_CR36","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/carcin\/bgz102","volume":"40","author":"RC Chai","year":"2019","unstructured":"Chai RC, Zhang KN, Chang YZ, Wu F, Liu YQ, Zhao Z, et al. Systematically characterize the clinical and biological significances of 1p19q genes in 1p\/19q non-codeletion glioma. Carcinogenesis. 2019;40:1229\u201339. https:\/\/doi.org\/10.1093\/carcin\/bgz102.","journal-title":"Carcinogenesis"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07464-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07464-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07464-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T14:17:15Z","timestamp":1769782635000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07464-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7464"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07464-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Zhongnan Hospital of Wuhan University approved this prospective study (No. 2021110), and all patients signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}